As of Sep 04
| +0.30 / +0.75%|
The 8 analysts offering 12-month price forecasts for Medicines Co have a median target of 43.50, with a high estimate of 53.00 and a low estimate of 28.00. The median estimate represents a +7.62% increase from the last price of 40.42.
The current consensus among 9 polled investment analysts is to Buy stock in Medicines Co. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.